(Q34572601)

3 August 2017

1 reference

title

Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective (English)

1 reference

3 August 2017

0 references

Hays SM

1

1 reference

3 August 2017

Becker RA

2

1 reference

3 August 2017

Leung HW

3

1 reference

3 August 2017

Aylward LL

4

1 reference

3 August 2017

Pyatt DW

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

6 October 2006

1 reference

Regulatory Toxicology and Pharmacology

3 August 2017

1 reference

3 August 2017

47

1 reference

3 August 2017

96-109

1 reference

3 August 2017

1

1 reference

A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady state.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Differential sensitivity of children and adults to chemical toxicity. II. Risk and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Di-alkyl phosphate biomonitoring data: assessing cumulative exposure to organophosphate pesticides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

[Risk assessment of soil contamination in a residential area: the importance and role of human biological monitoring--a case report]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Levels of PCDD/PCDF in blood fat as indices of the PCDD/PCDF body burden in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Application of toxicokinetic models to establish biological exposure indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Reconstruction of methylmercury intakes in indigenous populations from biomarker data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

The use of biological markers in toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Use of physiologically based pharmacokinetic models to establish biological exposure indexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Application of pharmacokinetics to derive biological exposure indexes from threshold limit values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Exposure assessment: serum levels of TCDD in Seveso, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

Biological exposure indicators: quantification of biological variability using toxicokinetic modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.08.004

10.1016/J.YRTPH.2006.08.004

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference